Stock Analysis

Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results

XTRA:GXI
Source: Shutterstock

Gerresheimer AG (ETR:GXI) shareholders are probably feeling a little disappointed, since its shares fell 4.1% to €99.50 in the week after its latest quarterly results. It was a credible result overall, with revenues of €466m and statutory earnings per share of €3.48 both in line with analyst estimates, showing that Gerresheimer is executing in line with expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Gerresheimer after the latest results.

View our latest analysis for Gerresheimer

earnings-and-revenue-growth
XTRA:GXI Earnings and Revenue Growth April 14th 2024

Taking into account the latest results, the current consensus from Gerresheimer's nine analysts is for revenues of €2.13b in 2024. This would reflect a credible 6.6% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to surge 26% to €4.28. Before this earnings report, the analysts had been forecasting revenues of €2.13b and earnings per share (EPS) of €4.23 in 2024. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

The analysts reconfirmed their price target of €132, showing that the business is executing well and in line with expectations. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Gerresheimer at €200 per share, while the most bearish prices it at €115. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We can infer from the latest estimates that forecasts expect a continuation of Gerresheimer'shistorical trends, as the 8.8% annualised revenue growth to the end of 2024 is roughly in line with the 8.9% annual growth over the past five years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 10% per year. So although Gerresheimer is expected to maintain its revenue growth rate, it's only growing at about the rate of the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at €132, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Gerresheimer going out to 2026, and you can see them free on our platform here..

We don't want to rain on the parade too much, but we did also find 1 warning sign for Gerresheimer that you need to be mindful of.

Valuation is complex, but we're helping make it simple.

Find out whether Gerresheimer is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.